News
Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Wrexham have taken a significant step toward boosting their stadium’s capacity, having officially submitted a planning application to Wrexham City Borough Council. The club aims to add an extra 2,250 ...
Matty James says he has been grateful for his "crazy" spell at Wrexham so far following a "whirlwind" summer last year. The ...
10d
Zacks Investment Research on MSNAnalysts Estimate Stoke Therapeutics, Inc. (STOK) to Report a Decline in Earnings: What to Look Out forThe market expects Stoke Therapeutics, Inc. (STOK) to deliver a year-over-year decline in earnings on higher revenues when it ...
Here are some of the largest recent moves: FMR LLC added 2,376,741 shares (+1438.7%) to their portfolio in Q1 2025, for an estimated $15,805,327 MARSHALL WACE, LLP added 1,180,351 shares (+124.1% ...
Find the latest analyst research, reports, and ratings for Stoke Therapeutics, Inc. Common Stock (STOK) at Nasdaq.com.
Here's what to know about Stok's commercial with Tatum and the Wrexham team. SUPER BOWL COMMERCIALS NEWS: Updated Super Bowl commercials tracker How much do Super Bowl ads cost in 2025?
STOK, the landmark 60,000 sq ft office building in Stockport, has completed the fit out of its final phase of 'plug and play' ...
The market expects Stoke Therapeutics, Inc. (STOK) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended June 2025. This widely-known ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results